Featured,Spotlight Stock,Trends & Articles Fun-Gal Snacks Introduces Crunchy Mushroom Chips By Dennis Mutua February 21, 2022 New York based company creating innovative snacks which harness the benefits of mushrooms and other underworld veggies Fun-Gal Snacks LLC has launched a flagship new crunchy mushroom chips dubbed ‘Popadelics’. The new vegan...
Featured,Spotlight Stock,Trends & Articles Nova Mentis Study Proves Oral Microdose Psilocybin Can Treat Autism By Dennis Mutua February 17, 2022 A study conducted by biotechnology company specializing on psilocybin based therapeutics and complementary diagnostics for neuroinflammatory disorders Nova Mentis Life Science Corp. (CSE: NOVA) (OTCQB: NMLSF) has confirmed that an...
Featured,Spotlight Stock,Trends & Articles Fluence Raises $3 Million to Level Up Psychedelic Therapy Training By Dennis Mutua February 16, 2022 Educational platform focusing on training in psychedelic and psychedelic-assisted psychotherapy Fluence announced having raised $3 million from its just concluded seed funding round. Following this financing round the company h...
Featured,Trends & Articles Oregon Releases First Set of Rules for its Therapeutic Psilocybin Program By Dennis Mutua February 15, 2022 Newly created Oregon Psilocybin Services section of the Oregon Health Authority has released the draft rules for the state’s therapeutic psilocybin program. This comes at a time when the state is preparing to launch its legal ps...
Featured,Spotlight Stock,Trends & Articles Health Canada Includes Mydecine’s Dealer License as a Supplier for the SAP in Canada By Dennis Mutua February 09, 2022 Biotechnology and digital technology developing innovative second and third generation novel compounds to treat mental health and addiction Mydecine Innovations Group. (NEO: MYCO) (OTCMKTS: MYCOF) announced that its exclusive deal...
Featured,Spotlight Stock,Trends & Articles Psyence Receives ISO Certification for its Natural Psilocybin Production Facility through BSI By Dennis Mutua February 08, 2022 Life science biotechnology company specializing on using naturally extracted psilocybin for long-term treatment of trauma and its mental health results Psyence Group Inc. (CSE: PSYG) (OTCQB: PSYGF) announced having receives Intern...
Spotlight Stock,Trends & Articles Silo Pharma Extends Option Agreement for Homing Peptides With the University of Maryland By Dennis Mutua February 07, 2022 Development stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research to treat PTSD, Alzheimer’s disease, and other neurological disorders Silo Pharma Inc. (OTCMKTS: SILO) has extended...
Featured,Spotlight Stock,Trends & Articles Entheon Biomedical Granted Approval for DMT Clinical Trial By Dennis Mutua February 04, 2022 Biotechnology company focused on research and development of psychedelics medicines to provide personalized treatment for addiction disorders Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) announced having being granted appro...